Clinical Trial Update: Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing adjuvant epirubicin/cyclophosphamide followed by a taxane versus epirubicin/taxane for node-positive breast cancer has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Epirubicin (epirubicin)
• Taxane (unspecified) (taxane)

Snippet

Sponsor: Pfizer | Conditions: Adenocarcinoma | Phase 3 | Status: COMPLETED